Clinical Trial Update: Study of the Effectiveness of Ozurdex for the Control of Uveitis [Phase 4]

View source ↗

Summary

Phase 4 study assessing the effectiveness of Ozurdex (dexamethasone implant) for control of uveitis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermediate Uveitis
• Posterior Uveitis
• Uveitis

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Johns Hopkins University | Conditions: Uveitis, Intermediate, Uveitis, Posterior | Phase 4 | Status: COMPLETED | Results posted: 2019-07-05